Savaysa
Generic name: Edoxaban
Drug class:
Factor Xa inhibitors
Usage of Savaysa
Savaysa blocks the activity of certain clotting substances in the blood.
Savaysa is used to lower the risk of stroke caused by a blood clot in people with a heart rhythm disorder called atrial fibrillation. This medicine is used when the atrial fibrillation is not caused by a heart valve problem.
Savaysa is also used to treat a type of blood clot called deep vein thrombosis (DVT), which can lead to blood clots in the lungs (pulmonary embolism). Savaysa should be used after 5 to 10 days of using an injectable blood thinner.
Savaysa side effects
Get emergency medical help if you have signs of an allergic reaction to Savaysa: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Also seek emergency medical attention if you have symptoms of a spinal blood clot: back pain, numbness or muscle weakness in your lower body, or loss of bladder or bowel control.
Savaysa can cause you to bleed more easily. Call your doctor at once if you have signs of bleeding such as:
Common Savaysa side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Savaysa
You should not use Savaysa if you are allergic to edoxaban, or if you have active or uncontrolled bleeding.
Savaysa can cause a very serious blood clot around your spinal cord if you undergo a spinal tap or receive spinal anesthesia (epidural). This type of blood clot could cause long-term paralysis, and may be more likely to occur if:
Savaysa may cause you to bleed more easily, especially if you have:
Tell your doctor if you have ever had:
Taking edoxaban during pregnancy may cause bleeding in the mother or the unborn baby. Tell your doctor if you are pregnant or if you become pregnant.
You should not breast-feed while using edoxaban.
Relate drugs
- Apixaban
- Arixtra
- Bevyxxa
- Edoxaban
- Eliquis
- Fondaparinux
- Rivaroxaban
- Savaysa
- Xarelto
- Xarelto Starter Pack
How to use Savaysa
Usual Adult Dose for Atrial Fibrillation:
60 mg orally once a day Use: Prevention of stroke and systemic embolism in nonvalvular atrial fibrillation
Usual Adult Dose for Deep Vein Thrombosis:
60 mg orally once a day following 5 to 10 days of initial therapy with a parenteral anticoagulant; your dose may be lower if you have a low weight. Uses: Treatment of deep venous thrombosis and pulmonary embolism following 5-10 days of initial parenteral anticoagulant therapy
Usual Adult Dose for Pulmonary Embolism:
60 mg orally once a day following 5 to 10 days of initial therapy with a parenteral anticoagulant; your dose may be lower if you have a low weight. Uses: Treatment of deep venous thrombosis and pulmonary embolism following 5-10 days of initial parenteral anticoagulant therapy
Warnings
Savaysa can cause you to bleed more easily. Call your doctor at once if you have signs of bleeding such as: bleeding gums, nosebleeds, heavy menstrual periods or abnormal vaginal bleeding, blood in your urine, bloody or tarry stools, coughing up blood or vomit that looks like coffee grounds.
Many other drugs can increase your risk of bleeding when used with Savaysa. Tell your doctor about all medicines you have recently used.
Savaysa can cause a very serious blood clot around your spinal cord if you undergo a spinal tap or receive spinal anesthesia (epidural). Tell any doctor who treats you that you are taking this medicine.
Do not stop taking Savaysa without first talking to your doctor. Stopping suddenly can increase your risk of blood clot or stroke.
What other drugs will affect Savaysa
Tell your doctor about all your other medicines, especially:
This list is not complete and many other drugs may interact with edoxaban. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions